Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis

Glucocorticoid-induced osteoporosis (GIOP) is a serious problem for patients with rheumatic diseases requiring long-term glucocorticoid treatment. Alendronate, a bisphosphonate, has been recommended in the prevention of GIOP. However, the efficacy and safety of alendronate in preventing GIOP remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Shun-Li, Yuan, Zhi-Fang, Li, Yan, Ai, Jie, Xu, Hong, Sun, Jing-Cheng, Feng, Shi-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998340/
https://www.ncbi.nlm.nih.gov/pubmed/27336902
http://dx.doi.org/10.1097/MD.0000000000003990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998340/
https://www.ncbi.nlm.nih.gov/pubmed/27336902
http://dx.doi.org/10.1097/MD.0000000000003990

Ejemplares similares